Skip banner and top navigation
NHLBI Logo and Link
National Heart, Lung, and Blood Institute: People, Science, Health
 HOME  SITE INDEX  CONTACT US
  
  Patient Recruitment - Dysbetalipoproteinemia (Type III)
TIPS     ADVANCED SEARCH
 

Research Studies        
Dysbetalipoproteinemia (Type III) Research Study - Diagnosis and Followup Protocol

Dysbetalipoproteinemia (Type III) Research Study

Dysbetalipoproteinemia (Type III) Research Study - Diagnosis and Followup Protocol

If you have Dysbetalipoproteinemia (Type III), you are invited to participate in a study in an attempt to diagnose and follow your disorder. There are several known causes of Dysbetalipoproteinemia and they include the E2E2 isoforms of apolipoprotein E (apoE), a mutation in apoE or apoE deficiency. Most untreated patients have a total cholesterol and triglycerides of 400-500 mg/dL. Some patients present with cholesterol deposits across the creases of their hands (palmar xanthomas), tuberous xanthomas on the elbows or knees and occasionally on the achilles tendon.

Eligible persons will undergo a comprehensive evaluation at no cost to you. All patients will remain under the care of their own physician who will receive results of the laboratory and diagnostic tests. In many cases, you will be invited back for yearly evaluations related to other studies. There is no cost to you for travel and for some of your medications.

For further information please contact our research coordinator (tel. 301-496-1500, e-mail: LipidStudy@nhlbi.nih.gov ).
 
Email This Study To A Friend       View/Print PDF Version Of This Study

Disease and Treatment Information
 

 
 
Spacer

NHLBI HOME · ACCESSIBILITY INFORMATION · NHLBI AT THE CLINICAL CENTER · PRIVACY STATEMENT · SUPPORTED BROWSERS · WEB TECHNICAL CONTACT· v1.2.0.1